The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.32BCNY
794.75M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue (TTM)
1.31BCNY
196.08M · vs all stocks (USD)
Updated Sep 22, 2026
Profit Margin
-2.92%
vs Pollution & Treatment Controls peers
Updated Sep 22, 2026
Beta
1.19x
vs all stocks
Updated Sep 22, 2026
52-Week Change
92.52%
vs all stocks
Updated Sep 22, 2026
Market Capitalization
5.32BCNY
794.75M · vs all stocks (USD)
Updated Sep 22, 2026
Enterprise Value
5.27BCNY
786.56M · vs all stocks (USD)
Updated Sep 22, 2026
Price to Sales (TTM)
4.05x
vs Pollution & Treatment Controls peers
Updated Sep 22, 2026
Price to Book (MRQ)
4.88x
vs Pollution & Treatment Controls peers
Updated Sep 22, 2026
Enterprise to Revenue
4.01x
vs Pollution & Treatment Controls peers
Updated Sep 22, 2026
Enterprise to EBITDA
108.37x
vs Pollution & Treatment Controls peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 104.04×.Updated Sep 22, 2026
Gross Margin
18.58%
vs Pollution & Treatment Controls peers
Updated Sep 22, 2026
Profit Margin
-2.92%
vs Pollution & Treatment Controls peers
Updated Sep 22, 2026
Operating Margin
-0.45%
vs Pollution & Treatment Controls peers
Updated Sep 22, 2026
Return on Assets (TTM)
0.38%
vs Pollution & Treatment Controls peers
Updated Sep 22, 2026
Return on Equity (TTM)
-2.78%
vs Pollution & Treatment Controls peers
Updated Sep 22, 2026
Revenue (TTM)
1.31BCNY
196.08M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue per Share (TTM)
9.87CNYUpdated Sep 22, 2026
Quarterly Revenue Growth
-16.70%
vs Pollution & Treatment Controls peers
Updated Sep 22, 2026
Gross Profit (TTM)
221.64MCNY
33.08M · vs all stocks (USD)
Updated Sep 22, 2026
EBITDA (TTM)
50.65MCNY
7.56M · vs all stocks (USD)
Updated Sep 22, 2026
Net Income (TTM)
-38.33MCNY
-5.72M · vs all stocks (USD)
Updated Sep 22, 2026
Quarterly Earnings Growth (YoY)
15.82%
vs Pollution & Treatment Controls peers
Updated Sep 22, 2026
Operating Cash Flow (TTM)
67.78MCNY
10.12M · vs all stocks (USD)
Updated Sep 22, 2026
Levered Free Cash Flow (TTM)
-65.11MCNY
-9.72M · vs all stocks (USD)
Updated Sep 22, 2026
5-Year Average Dividend Yield
0.91%
vs all stocks
Updated Sep 22, 2026
Payout Ratio
0.00%
vs Pollution & Treatment Controls peers
Updated Sep 22, 2026
Minority Interest (Equity)
9.55MCNYFY2025 · Dec 31, 2025
Revenue
1.39BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.16BCNYFY2025 · Dec 31, 2025
Gross Profit
220.90MCNYFY2025 · Dec 31, 2025
Operating Income
37.16MCNY
5.55M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-36.23MCNYFY2025 · Dec 31, 2025
Income Tax Expense
4.44MCNYFY2025 · Dec 31, 2025
Net Income
-40.67MCNYFY2025 · Dec 31, 2025
EBIT
-23.37MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
50.65MCNYFY2025 · Dec 31, 2025
Research & Development
40.51MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
41.57MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
9.14MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.24MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
12.86MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.3200CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.3200CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
130.76MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
130.76MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-40.67MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-1.17MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
53.90MCNYFY2025 · Dec 31, 2025
Free Cash Flow
34.75MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
269.42MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-40.67MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
16.94MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
44.62MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
33.02MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-19.15MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-105.60MCNYFY2025 · Dec 31, 2025
Sale of Investments
97.10MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-2.49MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-30.14MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
191.35MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-203.56MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-17.48MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-893.83KCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-30.58MCNYFY2025 · Dec 31, 2025
Shares Outstanding
131.69MSharesUpdated Sep 22, 2026
Float Shares
72.30MSharesUpdated Sep 22, 2026
% Held by Insiders
55.08%
vs all stocks
Updated Sep 22, 2026
% Held by Institutions
4.64%
vs all stocks
Updated Sep 22, 2026
Total Cash (MRQ)
348.31MCNY
51.99M · vs all stocks (USD)
Updated Sep 22, 2026
Total Cash per Share (MRQ)
2.65CNYUpdated Sep 22, 2026
Total Debt (MRQ)
280.49MCNY
41.87M · vs all stocks (USD)
Updated Sep 22, 2026
Total Debt to Equity (MRQ)
0.2540x
vs Pollution & Treatment Controls peers
Updated Sep 22, 2026
Current Ratio (MRQ)
1.34x
vs Pollution & Treatment Controls peers
Updated Sep 22, 2026
Book Value per Share (MRQ)
8.29CNYUpdated Sep 22, 2026
Total Assets
2.92BCNY
436.49M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.12BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.81BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
807.55MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
110.99MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.70BCNYFY2025 · Dec 31, 2025
Cash
307.34MCNYFY2025 · Dec 31, 2025
Cash Equivalents
50.67MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
358.02MCNYFY2025 · Dec 31, 2025
Accounts Receivable
1.29BCNYFY2025 · Dec 31, 2025
Inventory
35.91MCNYFY2025 · Dec 31, 2025
Accounts Payable
1.26BCNYFY2025 · Dec 31, 2025
Short-term Debt
208.98MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
81.33MCNYFY2025 · Dec 31, 2025
Long-term Debt
80.73MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
24.40MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
131.69MCNYFY2025 · Dec 31, 2025
Retained Earnings
254.43MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.11BCNY
165.65M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
17.50CNYUpdated Sep 22, 2026
52-Week High
75.50CNYUpdated Sep 22, 2026
52-Week Change
92.52%
vs all stocks
Updated Sep 22, 2026
Beta
1.19x
vs all stocks
Updated Sep 22, 2026
50-Day MA
37.71CNYUpdated Sep 22, 2026
200-Day MA
44.57CNYUpdated Sep 22, 2026
Avg 10-Day Volume
4.07MSharesUpdated Sep 22, 2026
Avg 30-Day Volume
4.82MSharesUpdated Sep 22, 2026
Diluted EPS (TTM)
-0.2900CNYUpdated Sep 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.